Portal vein thrombosis following a primary cytomegalovirus infection in an immunocompetent adult

Thrombosis and Haemostasis

Volumn 95, Issue 1, 2006, Pages 199-201

  Gueddi, Salah ^a   Righini, Marc ^a   Mezger, Nathalie ^a   Morard, Isabelle ^a   Kaiser, Laurent ^a   Giostra, Emiliano ^a   Bounameaux, Henri ^a   Angelillo Scherrer, Anne ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; VIRUS DNA;

ABDOMINAL PAIN; ADULT; ANTIBODY DETECTION; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COUGHING; CYTOMEGALOVIRUS INFECTION; ECHOGRAPHY; FATIGUE; FEVER; HUMAN; IMMUNOCOMPETENCE; LEUKOCYTOSIS; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MALE; POLYMERASE CHAIN REACTION; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SPLENOMEGALY; STREPTOCOCCUS GROUP A; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 33645550492     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612585     Document Type: Article

References (47)

1. Klemola E, Kaariainen L. Cytomegalovirus as a possible cause of a disease infectious mononucleosis. Br Med J 1965; 5470: 1099-102.
2. Eddleston M, Peacock S, Juniper M et al. Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 1997; 24: 52-6.
3. Madalosso C, de Souza NF, Jr., Ilstrup DM et al. Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. Transplantation 1998; 66: 294-7.
4. Min KW, Wickemeyer WJ, Chandran P, et al. Fatal cytomegalovirus infection and coronary arterial thromboses after heart transplantation: a case report. J Heart Transplant 1987; 6: 100-5.
5. Oh CK, Pelletier SJ, Sawyer RG et al. Uni- and multi-variate analysis of risk factors for early and late hepatic artery thrombosis after liver transplantation. Transplantation 2001; 71: 767-72.
6. Conway MD, Tong P, Olk RJ. Branch retinal artery occlusion (BRAO) combined with branch retinal vein occlusion (BRVO) and optic disc neovascularization associated with HIV and CMV retinitis. Int Ophthalmol 1995; 19: 249-52.
7. Jenkins RE, Peters BS, Pinching AJ. Thromboembolic disease in AIDS is associated with cytomegalovirus disease. Aids 1991; 5: 1540-2.
8. Meyohas MC, Roullet E, Rouzioux C et al. Cerebral venous thrombosis and dual primary infection with human immunodeficiency virus and cytomegalovirus. J Neurol Neurosurg Psychiatry 1989; 52: 1010-1.
9. Schiemann U, Steins M, Knospe V et al. Coincidence of cytomegalovirus retinitis and central retinal vein occlusion in a patient with hemophilia B and AIDS. AIDS Patient Care STDS 1999; 13: 7-9.
10. Smith KJ, Skelton HG, Yeager J et al.. Cutaneous thrombosis in human immunodeficiency virus type 1-positive patients and cytomegalovirus viremia. Arch Dermatol 1995; 131: 357-8.
11. Vielhauer V, Schewe CK, Schlondorff D. Bilateral thrombosis of the internal jugular veins with spasmodic torticollis in a patient with acquired immunodeficiency syndrome and disseminated cytomegalovirus infection. J Infect 1998; 37: 90-1.
12. Abgueguen P, Delbos V, Chennebault JM et al. E. Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review. Clin Infect Dis 2003; 36: E134-9.
13. Ailani RK, Simms R, Caracioni AA et al. Extensive mesenteric inflammatory veno-occlusive disease of unknown etiology after primary cytomegalovirus infection: first case. Am J Gastroenterol 1997; 92: 1216-8.
14. Arav-Boger R, Reif S, Bujanover Y. Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection. J Pediatr 1995; 126: 586-8.
15. Bauduer F, Blanc A, Cordon B. Deep vein thrombosis and acute cytomegalovirus infection: case report and review of the literature. Blood Coagul Fibrinolysis 2003; 14: 489-91.
16. Benoist S, Laisne MJ, Joly F et al. Cytomegalovirus infection as a cause of acute superior mesenteric vein thrombosis with jejunal infarction. Surgery 2003; 133: 222-3.
17. de Celis G, Mir J, Casal J et al. 31-year-old woman with an enlarged tender liver. Lancet 1995; 346: 1270.
18. Duenas C, Grande C, Martin A et al. [Mesenteric thrombosis associated with cytomegalovirus infection in an immunocompetent patient]. Enferm Infecc Microbiol Clin 2002; 20: 96-7.
19. Estival JL, Debourdeau P, Zammit C et al. [Spontaneous portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent patient]. Presse Med 2001; 30: 1876-8.
20. Inacio C, Hillaire S, Valla D et al. Case report: cytomegalovirus infection as a cause of acute portal vein thrombosis. J Gastroenterol Hepatol 1997; 12: 287-8.
21. Kinsara AJ, Khazindar A, Abdelaal MA. Cytomegalovirus-associated haemophagocytic syndrome and acute myocardial infarction in a young patient: possible association. J Intern Med 1998; 244: 91-2.
22. Labarca JA, Rabaggliati RM, Radrigan FJ et al. Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis 1997; 24: 197-200.
23. Lanari M, Lazzarotto T, Papa I et al. Neonatal aortic arch thrombosis as a result of congenital cytomegalovirus infection. Pediatrics 2001; 108: E114.
24. Ofotokun I, Carlson C, Gitlin SD et al. Acute cytomegalovirus infection complicated by vascular thrombosis: a case report. Clin Infect Dis 2001; 32: 983-6.
25. Uthman I, Tabbarah Z, Gharavi AE. Hughes syndrome associated with cytomegalovirus infection. Lupus 1999; 8: 775-7.
26. Wolf G, Porth J, Stahl RA. Thrombosis associated with cytomegalovirus infection in patients with ANCA-positive vasculitis. Am J Kidney Dis 2001; 38: E27.
27. Youd P, Main J, Jackson E. Cytomegalovirus infection and thrombosis: a causative association? J Infect 2003; 46: 141-2.
28. Squizzato A, Gerdes VE, Buller HR. Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost 2005; 93: 403-10.
29. Hadaya K, Kaiser L, Rubbia-Brandt L et al. Ganciclovir for severe cytomegalovirus primary infection in an immunocompetent child. Eur J Clin Microbiol Infect Dis 2004; 23: 218-20.
30. Kaiser L, Perrin L, Chapuis B et al. Improved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay. J Clin Microbiol 2002; 40: 4251-5.
31. Paya C, Humar A, Dominguez E et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004; 4: 611-20.
32. Janssen HL. Changing perspectives in portal vein thrombosis. Scand J Gastroenterol Suppl. 2000 (232): 69-73.
33. Vercellotti GM. Effects of viral activation of the vessel wall on inflammation and thrombosis. Blood Coagul Fibrinolysis 1998; 9 Suppl 2: S3-6.
34. Span AH, van Dam-Mieras MC, Mullers W et al. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest 1991; 21: 331-8.
35. Weis M, Kledal TN, Lin KY et al. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation 2004; 109: 500-5.
36. Nieto FJ, Sorlie P, Comstock GW, et al. Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link? Arterioscler Thromb Vasc Biol 1997; 17: 1780-5.
37. Schambeck CM, Hinney K, Gleixner J et al. Venous thromboembolism and associated high plasma factor VIII levels: linked to cytomegalovirus infection? Thromb Haemost. 2000; 83: 510-1.
38. Gharavi AE, Pierangeli SS, Harris EN. New developments in viral peptides and APL induction. J Autoimmun 2000; 15: 227-30.
39. Lemstrom KB, Bruning JH, Bruggeman CA et al. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest 1993; 92: 549-58.
40. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391-4.
41. Tanaka K, Zou JP, Takeda K et al. Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation 1999; 99: 1656-9.
42. Zhou YF, Yu ZX, Wanishsawad C et al. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor. Biochem Biophys Res Commun 1999; 256: 608-13.
43. Bruggeman CA, van Dam-Mieras MC. The possible role of cytomegalovirus in atherogenesis. Prog Med Virol 1991; 38: 1-26.
44. Epstein SE, Zhu J, Burnett MS et al. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000; 20: 1417-20.
45. Zhou YF, Leon MB, Waclawiw MA et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335: 624-30.
46. Neumann FJ, Kastrati A, Miethke T et al. Previous cytomegalovirus infection and risk of coronary thrombotic events after stent placement. Circulation 2000; 101: 11-3.
47. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73.